Ensign Peak Advisors, Inc Sangamo Therapeutics, Inc Transaction History

Ensign Peak Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $114,820 - $171,827	26,890 Added 585.84%	31,480 $154,000
Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $33,461 - $50,352	4,590 New	4,590 $34,000
Q3 2020 Nov 12, 2020	SELL	$9.38 - $12.48 $62,452 - $83,091	-6,658 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$5.05 - $8.85 $38,672 - $67,773	-7,658 Reduced 53.49%	6,658 $42,000
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $114,957 - $167,497	14,316 New	14,316 $119,000

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $178M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.